151 related articles for article (PubMed ID: 33035926)
1. Assessment of radionuclide impurities in [
Chiappiniello A; Iacco M; Rongoni A; Susta F; Sabatini P; Beneventi S; Tarducci R
Phys Med; 2020 Oct; 78():150-155. PubMed ID: 33035926
[TBL] [Abstract][Full Text] [Related]
2. Assessment of radionuclidic impurities in cyclotron produced (99m)Tc.
Lebeda O; van Lier EJ; Štursa J; Ráliš J; Zyuzin A
Nucl Med Biol; 2012 Nov; 39(8):1286-91. PubMed ID: 22796396
[TBL] [Abstract][Full Text] [Related]
3. Radionuclide impurities in proton-irradiated [18O]H2O for the production of 18F-: activities and distribution in the [18F]FDG synthesis process.
Bowden L; Vintró LL; Mitchell PI; O'Donnell RG; Seymour AM; Duffy GJ
Appl Radiat Isot; 2009 Feb; 67(2):248-55. PubMed ID: 19111472
[TBL] [Abstract][Full Text] [Related]
4. Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer ¹⁸F-fluoromethylcholine.
Hellberg S; Silvola JM; Kiugel M; Liljenbäck H; Metsälä O; Viljanen T; Metso J; Jauhiainen M; Saukko P; Nuutila P; Ylä-Herttuala S; Knuuti J; Roivainen A; Saraste A
Cardiovasc Diabetol; 2016 Feb; 15():26. PubMed ID: 26852231
[TBL] [Abstract][Full Text] [Related]
5. Determination of radionuclides and radiochemical impurities produced by in-house cyclotron irradiation and subsequent radiosynthesis of PET tracers.
Ishiwata K; Hayashi K; Sakai M; Kawauchi S; Hasegawa H; Toyohara J
Ann Nucl Med; 2017 Jan; 31(1):84-92. PubMed ID: 27744544
[TBL] [Abstract][Full Text] [Related]
6. Radionuclidic purity tests in (18)F radiopharmaceutIcals production process.
Dziel T; Tymiński Z; Sobczyk K; Walęcka-Mazur A; Kozanecki P
Appl Radiat Isot; 2016 Mar; 109():242-246. PubMed ID: 26553157
[TBL] [Abstract][Full Text] [Related]
7. Radioisotopic Purity of Sodium Pertechnetate 99mTc Produced with a Medium-Energy Cyclotron: Implications for Internal Radiation Dose, Image Quality, and Release Specifications.
Selivanova SV; Lavallée É; Senta H; Caouette L; Sader JA; van Lier EJ; Zyuzin A; van Lier JE; Guérin B; Turcotte É; Lecomte R
J Nucl Med; 2015 Oct; 56(10):1600-8. PubMed ID: 26205300
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of 18F-fluoromethylcholine PET/CT for imaging of vessel wall alterations in humans--first results.
Bucerius J; Schmaljohann J; Böhm I; Palmedo H; Guhlke S; Tiemann K; Schild HH; Biersack HJ; Manka C
Eur J Nucl Med Mol Imaging; 2008 Apr; 35(4):815-20. PubMed ID: 18183393
[TBL] [Abstract][Full Text] [Related]
9. Effective production of ⁶⁵Zn with a PET cyclotron.
Lucconi G; Cicoria G; Pancaldi D; Malizia C; Marengo M
Appl Radiat Isot; 2012 Aug; 70(8):1590-4. PubMed ID: 22732395
[TBL] [Abstract][Full Text] [Related]
10. Optimization of production yields, radionuclidic purity and hotcell shielding of SPECT and PET radionuclides produced by proton irradiation in variable energy 30 MeV cyclotrons--Part 67Ga.
Adam-Rebeles R; Van den Winkel P; De Vis L
Appl Radiat Isot; 2007 Sep; 65(9):995-1013. PubMed ID: 17624794
[TBL] [Abstract][Full Text] [Related]
11. Radionuclide impurities in [¹⁸F]F⁻ and [¹⁸F]FDG for positron emission tomography.
Köhler M; Degering D; Zessin J; Füchtner F; Konheiser J
Appl Radiat Isot; 2013 Nov; 81():268-71. PubMed ID: 23608142
[TBL] [Abstract][Full Text] [Related]
12. Impurities in Tc-99m radiopharmaceutical solution obtained from Mo-100 in cyclotron.
Tymiński Z; Saganowski P; Kołakowska E; Listkowska A; Ziemek T; Cacko D; Dziel T
Appl Radiat Isot; 2018 Apr; 134():85-88. PubMed ID: 29107513
[TBL] [Abstract][Full Text] [Related]
13. Internal radiation dose assessment of radiopharmaceuticals prepared with cyclotron-produced
Meléndez-Alafort L; Ferro-Flores G; De Nardo L; Bello M; Paiusco M; Negri A; Zorz A; Uzunov N; Esposito J; Rosato A
Med Phys; 2019 Mar; 46(3):1437-1446. PubMed ID: 30661241
[TBL] [Abstract][Full Text] [Related]
14. A fast and simple dose-calibrator-based quality control test for the radionuclidic purity of cyclotron-produced (99m)Tc.
Tanguay J; Hou X; Esquinas P; Vuckovic M; Buckley K; Schaffer P; Bénard F; Ruth TJ; Celler A
Phys Med Biol; 2015 Nov; 60(21):8229-47. PubMed ID: 26449791
[TBL] [Abstract][Full Text] [Related]
15. High-yield cyclotron production of
Nelson BJB; Wilson J; Schultz MK; Andersson JD; Wuest F
Nucl Med Biol; 2023; 116-117():108314. PubMed ID: 36708660
[TBL] [Abstract][Full Text] [Related]
16. Experimental and Monte Carlo characterization of radionuclidic impurities originated from proton irradiation of [
Alloni D; Prata M; Smilgys B
Appl Radiat Isot; 2019 Apr; 146():84-89. PubMed ID: 30763819
[TBL] [Abstract][Full Text] [Related]
17. Modeling of a Cyclotron Target for the Production of 11C with Geant4.
Chiappiniello A; Zagni F; Infantino A; Vichi S; Cicoria G; Morigi MP; Marengo M
Curr Radiopharm; 2018; 11(2):92-99. PubMed ID: 29651945
[TBL] [Abstract][Full Text] [Related]
18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
19. New method for production of
Moiseeva AN; Aliev RA; Furkina EB; Novikov VI; Unezhev VN
Nucl Med Biol; 2022; 106-107():52-61. PubMed ID: 35032789
[TBL] [Abstract][Full Text] [Related]
20. [Preparation, quality control and thyroid molecule imaging of solid-target based radionuclide ioine-124].
Zhu H; Wang F; Guo XY; Li LQ; Duan DB; Liu ZB; Yang Z
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 50(2):364-367. PubMed ID: 29643541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
